Eric Steiner

Cooley advised NGM Biopharmaceuticals (NGM Bio), a wholly owned subsidiary of NGM Bio Holdings and a privately held biotechnology company focused on discovering and developing transformative therapeutics for patients, on its $122 million Series A financing.

Cooley advised Instacart, the leading grocery technology company in North America, on its $660 million initial public offering.

Cooley advised Confluent on its offering of $1.1 billion aggregate principal amount of 0.00% convertible senior notes due 2027. Confluent has pioneered a new category of data infrastructure designed to connect all the applications, systems and data layers of a company around a real-time central nervous system. Partners Mischi a Marca, Jason Savich, Jon Avina, Milson Yu and Siana Lowrey led the Cooley team.

Cooley advised restaurant chain sweetgreen on its $418.6 million initial public offering of 14,950,000 shares of Class A common stock, which now trade on the New York Stock Exchange under the symbol SG. Partners Nick Hobson, David Peinsipp, Siana Lowrey and Charlie Kim led the Cooley team advising sweetgreen.

Cooley advised Confluent on its $828 million initial public offering of 23,000,000 shares of Class A common stock. Confluent trades on the Nasdaq Global Select Market under the symbol CFLT. Confluent has developed a new category of data infrastructure focused on data in motion, and its cloud-native platform is designed to be the intelligent connective tissue enabling real-time data from multiple sources to constantly stream across the organization. Jon Avina, Siana Lowrey and Milson Yu led the Cooley team.